Novo Slides as Amgen Update Fuels Obesity Drug Competition Fears
Novo Nordisk A/S shares slid on Friday as a US rival’s comments on an experimental obesity drug gave rise to concerns about potential new competition in the rapidly growing space.
Novo Nordisk A/S shares slid on Friday as a US rival’s comments on an experimental obesity drug gave rise to concerns about potential new competition in the rapidly growing space.
A strong US dollar and rising American wages are helping Philippine call centers extend more than two decades of growth, placing the industry on course to become the nation’s top foreign exchange earner by 2026, according to industry executives.
Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide.
Hong Kong stocks are on their longest winning streak since 2018, with a growing chorus of market watchers saying the worst of a years-long selloff is probably over.
Gabon is meeting with fixed-income investors this week as a rout fueled by fiscal and political risks rocks the central African nation’s bond market.
{{ video.ContentPackages[0].ScheduleStartDateTime | fromNow }}
{{ currentStream.Desc }}